MedTrace Logo

Ultrasound for Detection of Prostate Cancer

NCT05736094 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2024-04-05

No results posted yet for this study

Summary

Clinical proof of concept of dual-frequency ultrasound imaging for detection and visualization of prostate cancer.

Conditions

Interventions

DEVICE

SURF

Dual-frequency ultrasound

Sponsors & Collaborators

  • Norwegian University of Science and Technology

    collaborator OTHER

  • University of Oslo

    collaborator OTHER

  • The Research Council of Norway

    collaborator OTHER

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Wolfgang Lilleby, MD PhD · Oslo University Hospital

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-14
Primary Completion
2023-12-31
Completion
2024-03-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05736094 on ClinicalTrials.gov